Specifically, Li et al. demonstrated that m6A Methyltransferase METTL3 facilitates oxaliplatin resistance in CD133+ gastric cancer stem cells by Promoting PARP1 mRNA stability which increases base excision repair pathway activity (Li H. et al., 2022). Here, METTL3 is linked to gastric cancer.